NPI Details
DR. Padma Khanchustambham, M.D. is an internal medicine in Rancho Mirage, CA with 34 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Padma Khanchustambham, M.D. NPI is 1245243146. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a female.
The provider's business location address is:
35400 BOB HOPE DR
SUITE # 209
RANCHO MIRAGE, CA
ZIP 92270-772
Phone: (760) 699-7117
Fax: (760) 699-7750
The NPI 1245243146 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
- Injection of drug or substance under skin or into muscle (HCPCS:96372)
- Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
- Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
- Administration of influenza virus vaccine (HCPCS:G0008)
- Coronavirus vaccine 13 (HCPCS:91312)
- Fee covid-19 vac 13 res (HCPCS:0124A)
- Influenza vaccine split virus, preservative free (HCPCS:90662)
- Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
- Cervical or vaginal cancer screening; pelvic and clinical breast examination (HCPCS:G0101)
- Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
- Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit (HCPCS:G0438)
- Sarscov2 vac 30 mcg trs-sucr (HCPCS:91305)
- Adm sarscv2 30mcg trs-sucr b (HCPCS:0054A)
- Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
- Annual depression screening, 15 minutes (HCPCS:G0444)
- Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or (HCPCS:G2212)
- Fee covid-19 vac 14 res (HCPCS:0134A)
- Coronavirus vaccine 14 (HCPCS:91313)
- Transitional care management services for problem of high complexity (HCPCS:99496)
- Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and (HCPCS:G0180)
- Administration of pneumococcal vaccine (HCPCS:G0009)
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- Sarscov2 vac 50mcg/0.25ml im (HCPCS:91306)
- Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
- Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
- Breath test analysis for helicobacter pylori (HCPCS:83013)
- Administration of drug for helicobacter pylori (HCPCS:83014)
- Face-to-face behavioral counseling for obesity, 15 minutes (HCPCS:G0447)
- Transitional care management services for problem of moderate complexity (HCPCS:99495)
- New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
- Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted, for intramuscular use (HCPCS:91300)
The enumeration date for this NPI number is 8/14/2006 and was last updated on 6/8/2009.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207R00000X | Internal Medicine | | A86478 | CALIFORNIA | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | A86478 | OTHER | CALIFORNIA | STATE LICENSE ID |
| 2 | AV500Z | OTHER | CALIFORNIA | MEDICARE PTAN |
| 3 | 00A864780 | MEDICARE PIN | CALIFORNIA | |
| 4 | AV500Z | MEDICARE PIN | CALIFORNIA | |
| 5 | I35354 | MEDICARE UPIN | CALIFORNIA | |
